NO20085375L - Nitrerte hetrosykliske forbindelser som endotelin-reseptorantagonist - Google Patents

Nitrerte hetrosykliske forbindelser som endotelin-reseptorantagonist

Info

Publication number: NO20085375L
Authority: NO; Norway
Prior art keywords: receptor antagonist; endothelin receptor; heterocyclic compounds; nitrated; nitrated heterocyclic
Prior art date: 2006-05-29

Application number

NO20085375A

Other languages

English (en)

Norwegian (no)

Inventor

Nicoletta Almirante

Stefano Biondi

Ennio Ongini

Original Assignee

Nicox Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-05-29

Filing date

2008-12-23

Publication date

2009-02-25

2008-12-23 Application filed by Nicox Sa filed Critical Nicox Sa

2009-02-25 Publication of NO20085375L publication Critical patent/NO20085375L/no

Links

229940118365 Endothelin receptor antagonist Drugs 0.000 title abstract 2
239000002308 endothelin receptor antagonist Substances 0.000 title abstract 2
150000002391 heterocyclic compounds Chemical class 0.000 title 1
208000019693 Lung disease Diseases 0.000 abstract 1
230000000747 cardiac effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
230000003511 endothelial effect Effects 0.000 abstract 1
208000019622 heart disease Diseases 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
208000017169 kidney disease Diseases 0.000 abstract 1
150000002828 nitro derivatives Chemical class 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1
230000002685 pulmonary effect Effects 0.000 abstract 1
208000019553 vascular disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Vascular Medicine (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

NO20085375A 2006-05-29 2008-12-23 Nitrerte hetrosykliske forbindelser som endotelin-reseptorantagonist NO20085375L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06114617		2006-05-29
PCT/EP2007/055012 WO2007137980A1 (en)	2006-05-29	2007-05-23	Nitrated heterocyclic compounds as endothelin receptor antagonist

Publications (1)

Publication Number	Publication Date
NO20085375L true NO20085375L (no)	2009-02-25

Family

ID=38255421

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20085375A NO20085375L (no)	2006-05-29	2008-12-23	Nitrerte hetrosykliske forbindelser som endotelin-reseptorantagonist

Country Status (16)

Country	Link
US (1)	US20090263472A1 (de)
EP (1)	EP2021324B1 (de)
JP (1)	JP2009538862A (de)
KR (1)	KR20090020559A (de)
CN (1)	CN101454283A (de)
AR (1)	AR061598A1 (de)
AT (1)	ATE537144T1 (de)
AU (1)	AU2007267209A1 (de)
BR (1)	BRPI0711315A2 (de)
CA (1)	CA2652636A1 (de)
MX (1)	MX2008015289A (de)
NO (1)	NO20085375L (de)
NZ (1)	NZ571820A (de)
RU (1)	RU2008150440A (de)
WO (1)	WO2007137980A1 (de)
ZA (1)	ZA200808766B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR073259A1 (es) *	2008-07-29	2010-10-28	Merck & Co Inc	Derivados de furosemida utiles como diureticos
WO2010096320A2 (en) *	2009-02-18	2010-08-26	Bezwada Biomedical, Llc	Controlled release of nitric oxide and drugs from functionalized macromers and oligomers
EP2509594A1 (de) *	2009-12-09	2012-10-17	INSERM - Institut National de la Santé et de la Recherche Médicale	Endothelin-hemmer zur behandlung von rasch progressiver glomerulonephritis
WO2012152438A1 (en) *	2011-05-11	2012-11-15	Nicox S.A.	Process for the preparation of nitrate acid ester of organic compounds
EA035289B1 (ru) *	2013-10-18	2020-05-25	Аттоквант Диагностикс Гмбх	Способ диагностики первичного гиперальдостеронизма
CN116194449B (zh) *	2021-09-03	2024-07-26	深圳信立泰药业股份有限公司	一种内皮素a(eta)受体拮抗剂化合物及其制备方法和医药用途
CN113943266A (zh) *	2021-11-18	2022-01-18	广州楷石医药有限公司	一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
CN115959996B (zh) *	2022-01-28	2025-02-18	上海众强药业有限公司	No供体化合物及其药物组合物和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0841926B1 (de) *	1995-08-02	2003-03-26	Smithkline Beecham Corporation	Endothelinrezeptorantagonist
CA2391818A1 (en)	1996-03-13	1997-09-18	Queen's University At Kingston	Antagonism of endothelin actions
KR20010023615A (ko) *	1997-09-04	2001-03-26	스타르크, 카르크	신규 카르복실산 유도체, 그 제조 및 혼합 ｅｔａ/ｅｔｂ엔도텔린 수용체 길항제로서의 용도
TWI284642B (en)	1999-01-18	2007-08-01	Hoffmann La Roche	Novel heterocyclic sulfonamides
US6635273B1 (en)	1999-10-29	2003-10-21	Trustees Of Boston University	Methods of treating vascular diseases characterized by nitric oxide insufficiency
US20070238740A1 (en)	2003-08-28	2007-10-11	Nitromed, Inc.	Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use

2007
- 2007-05-23 KR KR1020087026471A patent/KR20090020559A/ko not_active Withdrawn
- 2007-05-23 CA CA002652636A patent/CA2652636A1/en not_active Abandoned
- 2007-05-23 AU AU2007267209A patent/AU2007267209A1/en not_active Abandoned
- 2007-05-23 JP JP2009512550A patent/JP2009538862A/ja not_active Withdrawn
- 2007-05-23 EP EP07729447A patent/EP2021324B1/de active Active
- 2007-05-23 WO PCT/EP2007/055012 patent/WO2007137980A1/en not_active Ceased
- 2007-05-23 US US12/300,026 patent/US20090263472A1/en not_active Abandoned
- 2007-05-23 CN CNA2007800199691A patent/CN101454283A/zh active Pending
- 2007-05-23 BR BRPI0711315-3A patent/BRPI0711315A2/pt not_active IP Right Cessation
- 2007-05-23 RU RU2008150440/04A patent/RU2008150440A/ru not_active Application Discontinuation
- 2007-05-23 NZ NZ571820A patent/NZ571820A/en not_active IP Right Cessation
- 2007-05-23 MX MX2008015289A patent/MX2008015289A/es active IP Right Grant
- 2007-05-23 AT AT07729447T patent/ATE537144T1/de active
- 2007-05-29 AR ARP070102313A patent/AR061598A1/es unknown
2008
- 2008-10-14 ZA ZA200808766A patent/ZA200808766B/xx unknown
- 2008-12-23 NO NO20085375A patent/NO20085375L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200808766B (en)	2010-01-27
US20090263472A1 (en)	2009-10-22
ATE537144T1 (de)	2011-12-15
EP2021324A1 (de)	2009-02-11
AU2007267209A1 (en)	2007-12-06
BRPI0711315A2 (pt)	2011-11-29
WO2007137980A1 (en)	2007-12-06
CN101454283A (zh)	2009-06-10
CA2652636A1 (en)	2007-12-06
MX2008015289A (es)	2008-12-12
AR061598A1 (es)	2008-09-10
NZ571820A (en)	2010-09-30
EP2021324B1 (de)	2011-12-14
RU2008150440A (ru)	2010-07-20
JP2009538862A (ja)	2009-11-12
KR20090020559A (ko)	2009-02-26

Legal Events

Date	Code	Title	Description
2012-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20085375L (no)	2009-02-25	Nitrerte hetrosykliske forbindelser som endotelin-reseptorantagonist
ATE483685T1 (de)	2010-10-15	1-benzensulfonyl-1h-indol-derivate als hemmer der ccr9-aktivität
NO20080408L (no)	2008-03-25	Azaindazolforbindelser og anvendelse derav
NO20083567L (no)	2008-10-16	Hydantoinderivater for behandling av inflammatoriske forstyrrelser
NO20083427L (no)	2008-10-14	Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
DK2321321T3 (da)	2012-05-21	Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister
NO20076648L (no)	2008-03-17	Novel thiophene derivatives
NO20092651L (no)	2009-09-14	Dihydropyridinderivater som er anvendelige som proteinkinaseinhibitorer
TR201905814T4 (tr)	2019-05-21	Jak inhibitörü olarak bipirazol tuzu.
NO20075298L (no)	2007-12-20	Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
NO20083630L (no)	2008-10-10	Nye pyridinderivater
EA200970835A1 (ru)	2010-04-30	Индазолы, применяемые для лечения расстройств, опосредуемых эстрогеновым рецептором бета
MX2010004705A (es)	2010-05-27	Derivados de piridazinona y uso de los mismos como inhibidores del receptor p2x7.
CR9304A (es)	2008-03-31	Antagonistas del receptor de glucagon, preparaciones y usos terapeuticos
NO20081893L (no)	2008-05-20	4-(3-aminopyrazol)pyrimidinderivater til anvendelse som tyrosin-kinaseinhibitorer i behandling av kreft
EA201190158A1 (ru)	2012-04-30	Производные бензофуранила для применения в качестве ингибиторов глюкокиназы
ATE482210T1 (de)	2010-10-15	Oxadiazolderivate als s1p1-rezeptor-agonisten
NO20080061L (no)	2008-04-07	Imidazolyl-pyrimidinforbindelser for anvendelse til behandling av proliferative lidelser
EA200901484A1 (ru)	2010-04-30	СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR
PH12018500261A1 (en)	2018-09-10	Azole benzene derivative
ATE542795T1 (de)	2012-02-15	Benzylpiperazinderivate als motilin- rezeptorantagonisten
DE602007012313D1 (de)	2011-03-10	Als a2b-adenosinrezeptorantagonisten geeignete 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4,5-büpyridin-2-onderivate
NO20071805L (no)	2007-06-07	Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere.
ATE432260T1 (de)	2009-06-15	Pyridinderivate als pkc-theta-hemmer
CL2009000236A1 (es)	2009-06-05	Compuestos derivados de triazolopiridazina, inhibidores de par1,procedimiento de preparacion y uso para profilaxis, prevencion y tratamiento de enfermedades asociadas con trombosis, embolia, hipercoagulabilidad, cambios fibroticos o trastornos inflamatorios.